SB-423562

Ainm Cheimiceach:

(R)-3-(4-ciana-3-(3-((1-(2,3-déhidrea-1H-indin-2-il)-2-meitilprópán-2-il)aimín)-2-hiodrocsaprópocsa )feanile) aigéad própánóch

Cód Smiles:

O=C(O)CCC1=CC=C(C#N)C(OC[C@H](O)CNC(C)(C)CC2CC3=C(C=CC=C3)C2)=C1

Cód InChi:

InChI=1S/C26H32N2O4/c1-26(2,14-19-11-20-5-3-4-6-21(20)12-19)28-16-23(29)17-32-24- 13-18(8-10-25(30)31)7-9-22(24)15-27/h3-7,9,13,19,23,28-29H,8,10-12,14, 16-17H2,1-2H3,(H,30,31)/t23-/m1/s1

Eochair InChi:

NJBFJCJKWWIKRD-HSZRJFAPSA-N

Eochairfhocal:

NPSP-795, SB-423562, SB-423562-A, SHP-635,SB-423562A, NPSP795,SB423562, SB423562A, SHP635,SB423562A, NPSP 7493, SHP-635, NPSP 7495, SHP ,SB 423562A

Tuaslagthacht: 

Stóráil: 

Cur síos:

Is antagonist receptor cailciam-bhraite é SB-423562 a d'fhéadfadh a bheith ann chun hipocalcemia ceannasach uathsomach a chóireáil

Sprioc: gabhdóir braite cailciam